Literature DB >> 8603939

Presence of human immunodeficiency virus (HIV) type 1 and HIV-1-specific antibodies in cervicovaginal secretions of infected mothers and in the gastric aspirates of their infants.

K Nielsen1, P Boyer, M Dillon, D Wafer, L S Wei, E Garratty, R E Dickover, Y J Bryson.   

Abstract

The presence of human immunodeficiency virus (HIV) in cervicovaginal secretions (CVS) may be a risk factor for perinatal transmission. CVS of 25 women were evaluated for HIV and HIV mucosal antibodies; 16 infants had gastric aspirates cultured. Maternal plasma HIV was measured by quantitative RNA polymerase chain reaction. Seven women (28%), 4 of 19 pregnant and 3 of 7 nonpregnant, had HIV in CVS. Two of 4 HIV-infected neonates had positive gastric aspirate cultures. The 4 pregnant women with HIV in CVS did not transmit infection. HIV-specific secretory IgA was present in CVS of 10 (42%) of 24 women (in 3 cases concurrent with virus). Plasma HIV RNA levels at delivery were higher among transmitters (mean, 68,921 copies/mL) than nontransmitters (mean, 9457 copies/mL). Intermittent HIV shedding in CVS occurred despite mucosal antibodies and did not necessarily correlate with maternal plasma HIV RNA copy number. The presence of HIV in newborn gastric aspirates may be a risk factor for perinatal infection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8603939     DOI: 10.1093/infdis/173.4.1001

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  6 in total

1.  Population genetic analysis of the protease locus of human immunodeficiency virus type 1 quasispecies undergoing drug selection, using a denaturing gradient-heteroduplex tracking assay.

Authors:  L Doukhan; E Delwart
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

2.  Antibody to human immunodeficiency virus type 1 (HIV-1) gp160 in mucosal specimens of asymptomatic HIV-1-infected volunteers parenterally immunized with an experimental recombinant HIV-1 IIIB gp160 vaccine. The National Institute of Allergy and Infectious Diseases-sponsored AIDS Vaccine Evaluation Group.

Authors:  J S Lambert; R Viscidi; M C Walker; B Clayman; M Winget; M Wolff; D H Schwartz
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

3.  Amniotic fluid exhibits an innate inhibitory activity against HIV type 1 replication in vitro.

Authors:  Azadeh Farzin; Pamela Boyer; Bonnie Ank; Karin Nielsen-Saines; Yvonne Bryson
Journal:  AIDS Res Hum Retroviruses       Date:  2012-12-07       Impact factor: 2.205

Review 4.  The role of cell-associated virus in mother-to-child HIV transmission.

Authors:  Caitlin Milligan; Julie Overbaugh
Journal:  J Infect Dis       Date:  2014-12-15       Impact factor: 5.226

5.  HIV-1 induces cytotoxic T lymphocytes in the cervix of infected women.

Authors:  L Musey; Y Hu; L Eckert; M Christensen; T Karchmer; M J McElrath
Journal:  J Exp Med       Date:  1997-01-20       Impact factor: 14.307

Review 6.  Prevention and control of HIV/AIDS.

Authors:  Madhu Choudhry; V P Choudhry
Journal:  Indian J Pediatr       Date:  2003-12       Impact factor: 1.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.